Z-1069-2025 Class II Ongoing
FDA device recall Z-1069-2025 was initiated by Murata Vios, Inc. on Apr 22, 2024 and is designated Class II. Reason for recall: During the set-up and workflow to begin Vios monitoring, it has been noticed that patient vital signs and ECG waveforms can become distorted and will flicker or flash very fast. This issue only… The recall status is ongoing. Affected quantity: 62 units.
Recall details
- Product Type
- Devices
- Report Date
- Feb 5, 2025
- Initiation Date
- Apr 22, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 62 units
Product description
muRata Vios Monitoring System Model 2050; bedside cardiac monitor, including cardiotachometer and alarm rate
Reason for recall
During the set-up and workflow to begin Vios monitoring, it has been noticed that patient vital signs and ECG waveforms can become distorted and will flicker or flash very fast. This issue only occurs on the Central Station Monitor (CSM) in the patient tiles view and is not seen at any other point during patient monitoring & not on the Bedside Monitor.
Distribution pattern
Worldwide - US Nationwide distribution in the states of NY, TX, OH, MD and the country of India.
Code information
Soft ware version 1.57.20, UDI: +B595BSM20500/$$7V1.57.20/16D20231129Y
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1069-2025
- openFDA file date
- Nov 17, 2026
- Loaded by RegDataLab
- Nov 18, 2026